Skip to main content

Psilocybin mushrooms, a traditional psychedelic similar to LSD in its action as a serotonin 5-HT2A receptor agonist, are currently under scientific examination for their potential role in psilocybin-assisted therapies. These therapies aim to treat a range of mental health disorders, encompassing major depression, anxiety, emotional distress, cluster headaches, and migraines.

In understanding the role that shrooms play in managing these disorders, it’s essential to investigate their metabolism within the body. This knowledge equips both researchers and users with insight into how the active compound triggers psychological and therapeutic effects. This article offers a basic guide to the pharmacology and pharmacokinetics of psilocybin.

[toc]
shrooms

Key Points:

  • Half of the ingested psychedelic fungi is absorbed and distributed throughout the body.
  • The fungal compound undergoes dephosphorylation, mainly in the liver, via the enzyme alkaline phosphatase.
  • Approximately 3.4% of the compound is eliminated in its original form within 24 hours, while the majority is excreted as a stable metabolite.

What is Pharmacokinetics?

Pharmacokinetics (PK) refers to the study of how substances, such as drugs, are processed by the body after entry into the system. It is a distinct yet related field to pharmacodynamics, which focuses on how a compound interacts with the body. PK explores four primary areas: absorption, distribution, metabolism, and excretion (ADME).

Comprehending these processes equips healthcare professionals to prescribe the most suitable medications with minimum risk. Furthermore, it allows for the customization of treatments according to an individual’s distinct physiology and lifestyle.

How Does Pharmacokinetics Relate to Psilocybin?

Psilocybin and psilocin, the primary active compounds in certain types of magic mushrooms, have garnered significant attention from both researchers and users. Pharmacokinetics studies how the body interacts with mushrooms that contain psilocybin, contributing to an understanding of their potential medicinal or recreational effects.

These compounds are referred to by various names, including “magic,” “psychedelic,” “medicinal,” or “sacred.” The fungi that harbor these compounds are consumed, with The varieties of these mushrooms, their origin, size, growth and drying conditions, and their age can lead to significant fluctuations in their concentrations.

While these mushrooms naturally grow in the wild, scientists have devised ways to produce them synthetically in laboratories. Both natural and lab-grown versions exhibit low toxicity, though minor side effects like nausea or vomiting may occur.

Despite these physiological side effects, the compounds present in these mushrooms have shown potential therapeutic benefits due to their safe profile and non-addictive properties. These benefits have encouraged researchers to explore their use in psychotherapy, particularly in treating anxiety and depression.

The 4 Stages of Pharmacokinetics

Psilocybin, the compound present in these mushrooms, is inactive in its original state and functions as a prodrug, converting into its active form, psilocin. Enzymes such as alkaline phosphatase facilitate this conversion, enabling psilocin to be absorbed and circulated throughout the body to reach various tissues. However, following oral administration, psilocybin cannot be detected in the circulatory system, feces, or urine.

Absorption

Absorption is the process by which the compound enters the bloodstream from the site of its administration. It affects the speed and effectiveness with which the compound reaches its target, like the plasma. Oral intake is the most common method of administration. Inhalation has been tried but is not as effective as oral consumption.

The absorption process also involves the release of the compound from its dosage form during oral intake. Factors such as a delay in the throat or esophagus can impact this, potentially delaying results or causing discomfort. Once the compound arrives in the stomach, the acidic environment may start to break it down before it enters the bloodstream.

Studies in animals show that only about 50% of orally administered psychedelics are absorbed and distributed throughout the body.

Factors Affecting the Absorption Process

Several factors can influence the absorption process, leading to differences in the onset, intensity, and duration of effects:

  1. Stomach Contents: A full stomach can delay absorption as it postpones the onset of effects. An empty stomach allows for quicker absorption.
  2. The term ‘Distribution’ denotes the process through which psilocin is transported throughout the body once it enters the bloodstream. As a lipophilic compound, psilocin has the ability to traverse the blood-brain barrier to reach the central nervous system.

    system.

    This process is shaped by various factors including the characteristics of the substance—such as its size, polarity, and protein-binding capabilities—and the individual’s physiological attributes, such as hydration status and body composition.

    The goal is to achieve a potent concentration at the target location. For effectiveness, the substance needs to reach its intended destination, as dictated by its distribution volume, and remain free from protein binding—thus allowing it to interact dynamically with its receptor.

    What Factors Shape the Distribution Process?

    The distribution process can be affected by numerous factors:

    1. Body Fat: Certain substances can accumulate in fat tissues, potentially prolonging their effects.
    2. Age: As age changes, so do metabolic rates and body composition.

    Effects usually begin to manifest within 20-40 minutes after ingestion, reaching their peak at approximately 80-100 minutes. The effects of magic mushrooms generally persist for 4-6 hours.

    How is Distribution to the Brain Managed?

    Preliminary research conducted on two species has shown that the binding affinity sequence is 5HT2A > 5HT1A > 5HT2B [23]. It also interacts with dopamine D1, 5HT1E, 5HT5A, 5HT7, 5HT6, D3, 5HT2C, and 5HT1B receptors.

    It acts as a partial agonist at the 5HT2A receptor, demonstrating around 40% efficacy. Its psychedelic effects can be traced back to its partial agonist activity at 5HT1A autoreceptors.

    The mood-lifting and psychotomimetic experiences are possibly due to the noted link between increased dopamine levels and sensations of depersonalization and euphoria. Hallucinogens work by modifying neurochemistry and receptor activity. They enhance 5HT2A agonist activity by promoting BDNF production in the hippocampus, which subsequently spurs neurogenesis and reduces conditioned fear-related behaviors.

    Elimination

    Elimination refers to the process by which the

    The human body expels substances via several mechanisms, primarily using the kidneys, but also through the lungs, skin, and gastrointestinal tract. In relation to the kidneys, these substances, particularly naturally occurring psychedelic drugs, are filtered in the glomerulus or secreted in the tubules. Some reabsorption also occurs, adding a layer of complexity to the elimination process.

    The primary compound has an average half-life of around 160 minutes, while the half-life of psilocin is approximately 50 minutes. Animal investigations reveal that this substance is primarily expelled through urine, constituting about 65% within 8 hours of ingestion. Residual traces of the substance can also be detected in smaller amounts in the bile and feces.

    In the human body, about 3.4% of the ingested substance is excreted in its unaltered state within 24 hours. However, most of it is expelled as psilocin-O-glucuronide, a more stable byproduct. This stability allows for the detection of the compound in urine samples over a prolonged timeframe.

    Substances are primarily expelled via two methods:

    1. Zero-Order Kinetics: The substance is eliminated at a constant rate, regardless of its concentration.
    2. First-Order Kinetics: The elimination rate is directly proportional to the concentration of the substance.

    Most psychedelic substances follow the first-order kinetics method, reaching a steady-state concentration after about four to five half-lives. Complete removal also occurs after approximately four to five half-lives.

    Discover Our Range of Psychedelic Mushrooms

    The metabolism of these substances varies among different mushroom species. When you purchase from reliable online vendors such as Shrooms For Sale Canada, you can steer clear of potentially harmful mushrooms. Some varieties, like the Agaric mushrooms, can produce intense and undesirable effects. Hence, it’s vital to procure magic mushrooms from trustworthy sources instead of resorting to uncertain street vendors or wild foraging.

    FeatureEnigmaFull Moon PartyGold Member
    Strain TypePsilocybe Cubensis OMNIPsilocybe cubensis (Thai Koh Samui)Psilocybe cubensis
    PotencyExceptionally high; 3.8% tryptamine contentModerately to highly potentHigh potency
    Visual CharacteristicsResembles a blob or Resembles a cauliflower or brain-like structureExhibits the typical appearance of cubensis, moderately sizedCharacteristic thick white stems, golden caramel caps, and evident blue bruising
    EffectsConsidered the most potent, known to produce intense effectsInduces a strong mental high with a delayed onset and prominent visualsProduces potent visuals and euphoria

    Online Guide to Psilocybin Mushroom Use

    For medical professionals, researchers, and users, understanding the pharmacokinetics of shrooms is crucial. This knowledge allows for more informed decisions regarding dosage and timing, thus reducing potential risks.

    Discover the psychedelic experience that suits you at Shrooms For Sale Canada. Whether you desire a soothing journey or a deeper exploration, our extensive product range is crafted to meet your unique needs. Experience top-quality, safe, and controlled shrooms, mitigating worries about uncertain sources or poisonous mushrooms.

    Experience the best magic mushrooms Canada has to offer and elevate your psychedelic journey to new heights.

    Frequently Asked Questions

    Are there any known interactions between shrooms and other medications?

    Our products may potentially interact with certain medications, particularly those affecting serotonin levels, like SSRIs (Selective Serotonin Reuptake Inhibitors). SSRIs and SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors) usually lessen the effects, unlike non-serotonergic antidepressants. This reduced effect can last up to three months after discontinuing the use of the antidepressant.

    Do all psychedelics follow the same pathway as psilocybin?

    No, each psychedelic substance has its unique structure, requiring different metabolic processes to activate, and they attach to various receptors in the body. The administration method also affects each psychedelic’s absorption. Although the basic principles of absorption, metabolism, and distribution are consistent, the specific pathways and effects vary with each substance.

    Can the form of the shroom affect the pharmacokinetics?

    Yes, the form (fresh, powdered, or dried mushrooms) can influence the absorption speed. For example, powdered forms may be absorbed faster than whole dried ones due to quicker dissolution.

    Related Articles:

Leave a Reply